- Home
- ANL vs BOWN Comparison
ANL vs BOWN Comparison
Compare ANL & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- BOWN
- Stock Information
- Founded
- ANL 2004
- BOWN 2023
- Country
- ANL Cayman Islands
- BOWN United States
- Employees
- ANL N/A
- BOWN N/A
- Industry
- ANL
- BOWN
- Sector
- ANL
- BOWN
- Exchange
- ANL Nasdaq
- BOWN Nasdaq
- Market Cap
- ANL 84.5M
- BOWN 100.3M
- IPO Year
- ANL 2023
- BOWN 2023
- Fundamental
- Price
- ANL $2.14
- BOWN $10.92
- Analyst Decision
- ANL Strong Buy
- BOWN
- Analyst Count
- ANL 2
- BOWN 0
- Target Price
- ANL $9.00
- BOWN N/A
- AVG Volume (30 Days)
- ANL 9.6K
- BOWN 39.8K
- Earning Date
- ANL 08-08-2024
- BOWN 01-01-0001
- Dividend Yield
- ANL N/A
- BOWN N/A
- EPS Growth
- ANL N/A
- BOWN N/A
- EPS
- ANL N/A
- BOWN 0.39
- Revenue
- ANL $5,000,000.00
- BOWN N/A
- Revenue This Year
- ANL N/A
- BOWN N/A
- Revenue Next Year
- ANL N/A
- BOWN N/A
- P/E Ratio
- ANL N/A
- BOWN $28.26
- Revenue Growth
- ANL N/A
- BOWN N/A
- 52 Week Low
- ANL $1.85
- BOWN $10.31
- 52 Week High
- ANL $17.48
- BOWN $10.98
- Technical
- Relative Strength Index (RSI)
- ANL 43.45
- BOWN 53.16
- Support Level
- ANL $2.23
- BOWN $10.93
- Resistance Level
- ANL $2.44
- BOWN $10.97
- Average True Range (ATR)
- ANL 0.19
- BOWN 0.02
- MACD
- ANL -0.01
- BOWN -0.00
- Stochastic Oscillator
- ANL 23.43
- BOWN 25.13
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.